Looking back on online marketplace stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Teladoc (NYSE:TDOC) and its peers.
The stocks featured in this article are seeing some big returns.
Over the past month, they’ve outpaced the market due to new product launches, positive news, or even a dedicated social media following.
A number of stocks fell in the afternoon session after a broader market sell-off triggered by renewed trade tensions. U.S. stock indices fell after the Trump administration announced intentions to impose a 35% tariff on many goods imported from Canada.
Shares of digital medical services platform Teladoc Health (NYSE:TDOC) jumped 3.5% in the afternoon session after the company received a price target increase from an analyst at Evercore ISI Group. Evercore ISI analyst Elizabeth Anderson raised the firm's price target on the virtual healthcare company to $8.00 from $7.00, while maintaining an "In-Line" rating on the shares.
Shares of digital medical services platform Teladoc Health (NYSE:TDOC) jumped 10.9% in the afternoon session after Citron Research published a report highlighting the company's growth potential following Teladoc's impressive updates at a Goldman Sachs Healthcare conference.
Generating cash is essential for any business, but not all cash-rich companies are great investments.
Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings.
However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.
Whether it be online shopping or social media, secular forces are propelling consumer internet businesses forward. These themes have enabled rapid growth for the industry,
which has posted a 1.4% gain over the past six months.
This was a good place to be as the S&P 500 was flat.
A number of stocks jumped in the afternoon session after the major indices rebounded, as the Bureau of Labor Statistics report revealed a resilient labor market with non-farm payrolls rising by 139,000 in May 2025, significantly above the consensus forecast of 125,000.
Wall Street has set ambitious price targets for the stocks in this article.
While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential.
However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial.
A number of stocks fell in the afternoon session after the major indices pulled back (Nasdaq -1.3%, S&P 500 - 1.4%) as Treasury yields rose, reflecting market anxiety over a draft federal budget that could worsen the already wide US fiscal deficit.
Digital medical services platform Teladoc Health (NYSE:TDOC) reported Q1 CY2025 results topping the market’s revenue expectations, but sales fell by 2.6% year on year to $629.4 million. The company expects next quarter’s revenue to be around $623.5 million, close to analysts’ estimates. Its non-GAAP loss of $0.01 per share was 96.5% above analysts’ consensus estimates.
Digital medical services platform Teladoc Health (NYSE:TDOC) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, but sales fell by 2.6% year on year to $629.4 million. The company expects next quarter’s revenue to be around $623.5 million, close to analysts’ estimates. Its GAAP loss of $0.53 per share was 57.8% below analysts’ consensus estimates.
